The Foundation for Angelman Syndrome Therapeutics is a nonprofit patient-advocacy group focused on Angelman syndrome, a rare genetic disorder. Its filings show it lobbies Congress on health issues, especially medical research, FDA rules, public health, and Medicaid. It has reported $150,000 in lobbying since 5 filings and used the law firm Faegre Drinker Biddle & Reath for advocacy.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVID RUSGAN ZOOK
The latest disclosures for this client.
FAEGRE DRINKER BIDDLE & REATH LLP
Q2FAEGRE DRINKER BIDDLE & REATH LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FAEGRE DRINKER BIDDLE & REATH LLP
MEGAN SUSSMAN HERBER
FAEGRE DRINKER BIDDLE & REATH LLP
FAEGRE DRINKER BIDDLE & REATH LLP
Q4FAEGRE DRINKER BIDDLE & REATH LLP
Q3FAEGRE DRINKER BIDDLE & REATH LLP
Q3FAEGRE DRINKER BIDDLE & REATH LLP
Q2FAEGRE DRINKER BIDDLE & REATH LLP
Q1